Vitamin Shoppe, Inc. VSI Cash Flow

Vitamin shoppe, inc. (VSI)

CashFlow / TTM

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Sep'18	Jun'18	Mar'18	Dec'17	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net income (loss)
-8,809	-7,146	3,604	-3,752	-	-16,003	-100,407	-264,006	-	-252,151	-246,187	-148,674	18,178	24,964	42,710	45,445	49,253	53,171	58,648	56,747	59,432	61,241	60,851	64,922	66,258	66,546	65,005	65,028	63,361	60,825	60,559	56,179	51,536	44,864	0	0	0
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of fixed assets, intangible assets and finance leases right-of-use assets
40,820	40,380	40,720	42,114	-	47,658	44,863	42,623	-	39,204	33,516	35,179	36,545	38,780	38,850	39,185	39,331	38,495	37,616	36,522	35,406	34,219	33,074	31,409	29,731	28,026	26,549	25,285	23,882	23,076	21,934	21,307	20,981	20,300	0	0	0
Impairment charges on intangible assets
9,000	9,000	0	8,174	-	8,174	67,579	67,579	-	59,405	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment charges on fixed assets
2,460	2,974	2,315	11,057	-	10,377	9,946	15,400	-	6,658	6,254	6,164	579	797	1,271	1,074	1,395	1,177	0	0	0	-	-	-	-	-	-	-	-	730	0	0	0	-	-	-	-
Discontinued operations charge
-	-	0	-	-	-	-	0	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Debt Issuance Costs
448	458	494	604	-	705	805	880	-	898	927	943	958	957	804	630	435	237	201	176	171	164	134	123	108	96	93	133	196	258	321	339	340	372	0	0	0
Contingent consideration for acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	959	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
673	673	4,400	16,902	-	16,229	16,229	12,502	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Amortization of Debt Discount (Premium)
2,212	2,262	2,491	3,170	-	3,782	4,389	4,810	-	4,781	4,825	4,780	4,734	4,690	3,657	2,501	1,357	223	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-711	0	0	0	-	-	-	0
Deferred income taxes
-11,735	-4,803	6,769	5,619	-	28,371	1,527	-20,219	-	-19,834	-48,719	-26,807	-13,835	-13,683	-3,303	-1,809	-986	-1,364	-4,594	-3,918	-4,143	-3,950	3,843	2,318	795	545	0	0	0	-	-	-	-	-1,476	0	0	0
Deferred rent
1,046	2,039	3,143	3,881	-	3,363	2,808	2,382	-	2,431	2,789	3,145	3,304	3,226	2,926	2,710	2,497	2,294	2,040	1,415	868	503	200	-450	-596	-810	-726	-196	-164	-292	-2,442	-1,998	-1,611	-1,068	0	0	0
Non-cash portion of lease expense for operating leases
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity compensation expense
1,760	2,679	2,420	2,663	-	3,725	4,343	5,397	-	6,122	5,723	5,468	6,182	6,292	5,481	5,539	5,058	5,491	5,856	6,592	7,132	6,901	7,265	7,767	8,395	8,333	8,637	7,960	7,010	6,500	6,066	5,664	5,485	5,166	0	0	0
Issuance of shares for services rendered
-	-	-	-	-	-	-	-	-	-	-	-	-	333	500	500	334	167	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefits on exercises of equity awards
-487	-499	-833	-792	-	-865	-975	-1,395	-	-1,017	-920	-909	-605	-739	-1,152	-1,131	-739	-509	0	0	0	-	-	-	3,395	2,074	25,273	18,470	13,826	12,332	-9,173	-1,384	955	1,108	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
0	487	-187	1,458	-	4,801	4,278	2,086	-	-1,102	-4,036	-2,423	215	-70	1,893	-1,048	-1,657	-2,939	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
-6,585	-21,759	-22,508	-33,052	-	-42,739	-17,279	-13,294	-	-10,573	15,825	-2,312	6,382	13,078	3,867	17,164	12,535	38,284	24,911	23,595	23,301	2,458	2,550	12,942	18,357	13,429	25,211	20,679	8,611	16,201	20,504	8,196	14,137	10,189	0	0	0
Prepaid expenses and other current assets
-17,317	-10,386	-11,494	-11,691	-	1,003	1,632	12,607	-	5,916	10,170	5,966	-1,594	8,521	-268	3,452	159	-3,889	-13,874	-8,553	4,903	-3,782	14,487	15,114	4,129	15,668	7,058	1,388	986	-558	6,256	5,363	4,149	4,259	0	0	0
Other long-term assets
1,020	1,099	1,043	16	-	683	673	675	-	598	-60	-60	-119	-116	-188	-159	-87	139	245	232	-2,380	-2,441	-2,286	-2,206	893	968	911	893	650	629	465	377	511	395	0	0	0
Accounts payable
-4,538	-16,307	-15,020	-7,104	-	-16,623	934	-411	-	-12,916	14,898	534	2,986	26,522	6,336	11,022	-915	-3,709	2,342	8,585	3,659	-9,869	-4,920	-13,391	3,319	11,688	4,410	11,507	8,122	2,226	4,854	4,716	177	3,978	0	0	0
Accrued expenses and other current liabilities
-3,012	-7,680	5,727	4,873	-	1,311	9,058	2,875	-	7,047	15,952	13,341	-3,221	2,921	-5,961	567	15,300	394	-3,508	4,439	9,351	8,483	15,663	7,815	7,549	-1,416	-647	7,702	3,862	15,842	14,928	5,620	9,551	13,641	0	0	0
Operating lease liabilities
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
-926	-918	-1,016	-497	-	1,109	1,759	2,550	-	2,094	846	707	435	747	849	2,182	2,485	2,735	-1,708	-698	383	1,395	-307	-151	-1,399	-1,779	5,760	1,189	1,002	496	-546	502	631	379	0	0	0
Net cash provided by operating activities
46,560	47,745	72,204	90,147	-	90,815	84,402	54,499	-	56,189	58,258	76,506	70,077	93,373	82,105	83,837	98,328	60,667	87,638	95,932	86,663	100,147	97,060	72,173	88,990	81,122	70,622	83,861	82,623	78,350	76,098	81,298	73,074	77,133	0	0	0
Cash flows from investing activities:
Capital expenditures
22,930	25,036	25,811	28,138	-	36,361	42,347	51,604	-	55,020	52,154	47,441	38,525	40,068	40,459	39,882	39,810	39,403	42,328	44,465	45,716	42,957	41,230	37,963	39,454	42,782	44,503	43,729	36,731	30,775	28,501	26,018	26,434	25,046	0	0	0
Acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-487	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of business
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Trademarks and other intangible assets
591	522	417	372	-	365	435	436	-	428	383	276	282	291	291	378	456	514	560	589	659	689	835	793	731	648	0	0	0	-	-	-	-	-	-	-	-
Net cash used in investing activities
-23,521	-26,440	-11,381	-13,663	-	-21,879	-27,053	-52,040	-	-55,448	-52,537	-47,717	-38,807	-40,359	-40,750	-40,260	-40,266	-39,430	-42,401	-44,567	-127,426	-125,184	-123,603	-120,526	-40,095	-93,650	-95,508	-94,378	-87,536	-31,174	-28,501	-26,018	-26,434	-25,046	0	0	0
Cash flows from financing activities:
Borrowings under revolving credit facility
48,000	92,000	123,000	163,000	-	153,000	142,000	126,000	-	118,000	121,000	104,000	109,000	82,000	71,000	55,000	44,000	47,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	12,000	0	0	0
Repayments of borrowings under revolving credit facility
48,000	95,000	158,000	175,000	-	165,000	142,000	91,000	-	117,000	115,000	116,000	115,000	79,000	73,000	58,000	56,000	47,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	30,000	0	0	0
Purchases of convertible notes
6,733	6,733	29,851	63,891	-	57,158	57,158	34,040	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bank overdraft
-1,666	1,732	4,477	601	-	457	114	-2,624	-	-3,265	-2,505	-2,430	-2,135	-1,041	774	5,310	2,576	6,973	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	135	105	343	720	1,052	1,429	1,593	1,659	1,732	0	0	0
Contingent consideration payment for acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of long term debt (Notes)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55,106	0	0	0
Borrowings of long term debt - term loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Proceeds from exercises of common stock options
-	-	-	-	-	-	-	-	-	1,500	1,511	1,594	1,601	90	94	355	569	1,352	4,091	6,193	8,388	9,393	8,421	6,024	4,802	3,487	1,815	6,965	10,375	11,236	11,454	7,135	6,073	6,087	0	0	0
Issuance of shares under employee stock purchase plan
397	416	266	290	-	393	307	416	-	469	557	751	820	823	710	725	849	892	939	959	914	923	914	685	650	849	637	829	815	721	1,095	1,093	1,074	917	0	0	0
Purchases of treasury stock
340	352	406	304	-	290	280	758	-	580	595	775	997	1,205	1,213	1,224	2,644	2,530	2,587	2,465	2,422	2,415	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of shares under Share Repurchase Programs
-	-	-	-	-	-	-	-	-	-	-	-	-	66,011	164,154	171,578	171,874	146,108	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefits on exercises of equity awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-739	-1,152	-1,131	-739	-509	460	1,746	3,851	5,363	6,096	5,024	3,395	2,074	1,011	7,618	11,446	12,332	11,389	3,600	1,261	1,108	0	0	0
Deferred financing fees and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	575	0	0	0
Other financing activities
-17	-11	11	17	-	-4	1	-326	-	-346	-570	-526	-131	-14	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-8,836	-8,425	-60,980	-75,764	-	-69,053	-57,467	-2,783	-	-1,662	-5,834	-28,755	-31,375	-65,304	-41,426	-44,993	-57,716	-18,428	-75,522	-63,233	-45,423	-36,877	4,513	8,624	7,772	5,463	3,078	14,926	21,916	23,237	3,674	-11,725	-40,341	-67,301	0	0	0
Effect of exchange rate changes on cash and cash equivalents
0	0	0	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
0	0	0	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	35	-6	-23	108	19	113	79	-104	129	105	171	214	44	-10	-81	-54	-67	0	0	0	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-886	-119	11	3	-12,271	42	-1,337	242	2,938	-30,180	-11,697	-85,972	-61,870	-22,040	-39,810	56,613	-7,132	-21,853	4,400	16,977	70,414	51,271	43,555	6,299	-15,214	0	0	0
Supplemental disclosures of cash flow information:
Interest paid
-	2,136	2,693	3,186	4,062	-	3,962	4,260	-	3,953	3,946	3,911	3,924	3,715	2,037	1,998	440	440	356	293	256	249	296	347	360	390	359	360	359	362	539	655	1,166	2,401	0	0	0
Income taxes paid (refunded)
-3,836	-3,804	-14,906	-14,915	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	33,716	-	38,276	38,675	32,088	33,659	33,991	32,880	38,694	37,652	42,886	46,561	42,286	57,064	52,669	44,196	44,196	30,817	32,418	38,454	29,839	28,199	0	0	0
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment
5,036	-1,110	59	1,935	-	-2,291	428	-2,392	-	4,457	8,880	8,873	10,991	4,630	6,207	7,957	7,430	7,497	4,847	8,356	6,998	8,379	10,313	7,346	7,438	7,106	6,616	6,582	8,875	5,064	8,400	8,034	5,618	4,991	0	0	0
Assets acquired under capital leases
-	-	-	-	-	-	-	-	-	891	891	2,480	2,480	1,589	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	264	0	0	0	-	-	-	-
Assets acquired under tenant incentives
-	-	-	-	-	-	-	-	-	2,986	2,986	2,986	2,986	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-